Real-time enrollment status for this metastatic malignant solid neoplasm clinical trial
Current Status
Recruiting
Checked: July 25, 2026 at 11:48 AM UTC
| NCT Number | NCT05372614 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Malignant Solid Neoplasm |
| Phase | PHASE1 |
| Target Enrollment | 58 participants |
| Active Locations | 18 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 24, 2026 (Yesterday) |
As of July 25, 2026: Clinical trial NCT05372614 is currently recruiting participants. This phase1 study for metastatic malignant solid neoplasm is actively seeking new participants at 18 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05372614 is actively recruiting participants as of July 25, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05372614 was last updated Yesterday (July 24, 2026). HelloStudys verifies this status automatically.